Annual Operating Profit
-$11.37 M
+$6.88 M+37.70%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual operating income is -$11.37 million, with the most recent change of +$6.88 million (+37.70%) on March 1, 2024.
- During the last 3 years, GRCE annual operating profit has fallen by -$651.00 thousand (-6.08%).
- GRCE annual operating profit is now -638.93% below its all-time high of -$1.54 million, reached on February 1, 2010.
Performance
GRCE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$4.83 M
+$132.00 K+2.66%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly operating income is -$4.83 million, with the most recent change of +$132.00 thousand (+2.66%) on September 1, 2024.
- Over the past year, GRCE quarterly operating profit has dropped by -$1.79 million (-58.76%).
- GRCE quarterly operating profit is now -2461.51% below its all-time high of -$188.60 thousand, reached on November 1, 2008.
Performance
GRCE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$16.10 M
-$2.74 M-20.50%
September 1, 2024
Summary
- As of February 8, 2025, GRCE TTM operating income is -$16.10 million, with the most recent change of -$2.74 million (-20.50%) on September 1, 2024.
- Over the past year, GRCE TTM operating profit has dropped by -$3.83 million (-31.23%).
- GRCE TTM operating profit is now -8436.59% below its all-time high of -$188.60 thousand, reached on November 1, 2008.
Performance
GRCE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
GRCE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.7% | -58.8% | -31.2% |
| 3 y3 years | -6.1% | +5.4% | +12.8% |
| 5 y5 years | +66.2% | +22.8% | -65.3% |
GRCE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.1% | +37.7% | -130.9% | +5.4% | -41.6% | +12.9% |
| 5 y | 5-year | -6.1% | +66.2% | -156.0% | +21.4% | -65.3% | +48.5% |
| alltime | all time | -638.9% | +66.2% | -2461.5% | +55.5% | -8436.6% | +53.7% |
Grace Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.83 M(-2.7%) | -$16.10 M(+20.5%) |
| Jun 2024 | - | -$4.96 M(+52.1%) | -$13.36 M(+17.5%) |
| Mar 2024 | -$11.37 M(-37.7%) | -$3.26 M(+7.2%) | -$11.37 M(-7.4%) |
| Dec 2023 | - | -$3.04 M(+45.5%) | -$12.27 M(-8.9%) |
| Sep 2023 | - | -$2.09 M(-29.5%) | -$13.47 M(-18.3%) |
| Jun 2023 | - | -$2.97 M(-28.7%) | -$16.49 M(-9.7%) |
| Mar 2023 | -$18.25 M(+19.0%) | -$4.17 M(-1.9%) | -$18.25 M(-1.3%) |
| Dec 2022 | - | -$4.25 M(-16.9%) | -$18.49 M(+0.1%) |
| Sep 2022 | - | -$5.11 M(+8.0%) | -$18.47 M(+9.1%) |
| Jun 2022 | - | -$4.73 M(+7.4%) | -$16.93 M(+10.3%) |
| Mar 2022 | -$15.34 M(+43.2%) | -$4.40 M(+4.2%) | -$15.34 M(+19.6%) |
| Dec 2021 | - | -$4.22 M(+18.4%) | -$12.82 M(+21.4%) |
| Sep 2021 | - | -$3.57 M(+13.4%) | -$10.56 M(+8.4%) |
| Jun 2021 | - | -$3.15 M(+66.7%) | -$9.74 M(-9.1%) |
| Mar 2021 | -$10.72 M(-56.2%) | -$1.89 M(-3.9%) | -$10.72 M(-16.7%) |
| Dec 2020 | - | -$1.96 M(-28.4%) | -$12.86 M(-24.5%) |
| Sep 2020 | - | -$2.74 M(-33.4%) | -$17.04 M(-17.1%) |
| Jun 2020 | - | -$4.12 M(+2.2%) | -$20.55 M(-15.9%) |
| Mar 2020 | -$24.44 M(-27.4%) | -$4.03 M(-34.4%) | -$24.44 M(-21.8%) |
| Dec 2019 | - | -$6.15 M(-1.7%) | -$31.26 M(-5.2%) |
| Sep 2019 | - | -$6.25 M(-21.9%) | -$32.98 M(-5.2%) |
| Jun 2019 | - | -$8.01 M(-26.2%) | -$34.80 M(+1.3%) |
| Mar 2019 | -$33.66 M(+120.7%) | -$10.85 M(+38.0%) | -$34.34 M(+18.7%) |
| Dec 2018 | - | -$7.86 M(-2.7%) | -$28.93 M(+15.0%) |
| Sep 2018 | - | -$8.08 M(+7.1%) | -$25.16 M(+22.0%) |
| Jun 2018 | - | -$7.54 M(+38.6%) | -$20.62 M(+35.4%) |
| Mar 2018 | -$15.25 M(+81.4%) | -$5.44 M(+32.9%) | -$15.23 M(+55.6%) |
| Dec 2017 | - | -$4.10 M(+15.9%) | -$9.78 M(+29.5%) |
| Sep 2017 | - | -$3.53 M(+64.2%) | -$7.56 M(+28.2%) |
| Jun 2017 | - | -$2.15 M(+15.1%) | -$5.89 M(-22.1%) |
| Mar 2017 | -$8.41 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | - | -$1.87 M(-0.1%) | -$7.57 M(-1.3%) |
| Aug 2016 | - | -$1.87 M(-17.5%) | -$7.67 M(+3.2%) |
| May 2016 | - | -$2.27 M(+45.7%) | -$7.43 M(+2.3%) |
| Feb 2016 | -$7.09 M(-28.4%) | -$1.56 M(-20.9%) | -$7.26 M(-2.0%) |
| Nov 2015 | - | -$1.97 M(+20.7%) | -$7.41 M(-7.7%) |
| Aug 2015 | - | -$1.63 M(-22.3%) | -$8.03 M(-16.2%) |
| May 2015 | - | -$2.10 M(+22.9%) | -$9.57 M(-6.3%) |
| Feb 2015 | -$9.91 M(+2.1%) | -$1.71 M(-34.0%) | -$10.21 M(+0.5%) |
| Nov 2014 | - | -$2.59 M(-18.6%) | -$10.16 M(-5.0%) |
| Aug 2014 | - | -$3.18 M(+16.1%) | -$10.69 M(+0.8%) |
| May 2014 | - | -$2.74 M(+65.6%) | -$10.60 M(+8.4%) |
| Feb 2014 | -$9.71 M(+42.4%) | -$1.65 M(-47.0%) | -$9.78 M(-1.5%) |
| Nov 2013 | - | -$3.12 M(+1.0%) | -$9.93 M(+17.6%) |
| Aug 2013 | - | -$3.09 M(+61.1%) | -$8.44 M(+18.8%) |
| May 2013 | - | -$1.92 M(+6.8%) | -$7.11 M(+5.1%) |
| Feb 2013 | -$6.82 M(+4.1%) | -$1.80 M(+9.8%) | -$6.76 M(+0.7%) |
| Nov 2012 | - | -$1.64 M(-6.7%) | -$6.71 M(-7.0%) |
| Aug 2012 | - | -$1.75 M(+11.6%) | -$7.22 M(-0.6%) |
| May 2012 | - | -$1.57 M(-10.2%) | -$7.26 M(+7.8%) |
| Feb 2012 | -$6.55 M(+105.4%) | -$1.75 M(-18.4%) | -$6.73 M(+8.6%) |
| Nov 2011 | - | -$2.14 M(+19.3%) | -$6.20 M(+28.4%) |
| Aug 2011 | - | -$1.80 M(+72.3%) | -$4.83 M(+31.4%) |
| May 2011 | - | -$1.04 M(-14.4%) | -$3.68 M(+16.9%) |
| Feb 2011 | -$3.19 M(+107.3%) | -$1.22 M(+57.8%) | -$3.15 M(+34.0%) |
| Nov 2010 | - | -$772.20 K(+20.3%) | -$2.35 M(+20.2%) |
| Aug 2010 | - | -$641.70 K(+25.2%) | -$1.95 M(+10.8%) |
| May 2010 | - | -$512.60 K(+22.1%) | -$1.76 M(+16.4%) |
| Feb 2010 | -$1.54 M | -$419.80 K(+10.9%) | -$1.51 M(+38.4%) |
| Nov 2009 | - | -$378.60 K(-16.1%) | -$1.09 M(+21.0%) |
| Aug 2009 | - | -$451.30 K(+70.6%) | -$904.40 K(+99.6%) |
| May 2009 | - | -$264.50 K(+40.2%) | -$453.10 K(+140.2%) |
| Nov 2008 | - | -$188.60 K | -$188.60 K |
FAQ
- What is Grace Therapeutics annual operating income?
- What is the all time high annual operating profit for Grace Therapeutics?
- What is Grace Therapeutics annual operating profit year-on-year change?
- What is Grace Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Grace Therapeutics?
- What is Grace Therapeutics quarterly operating profit year-on-year change?
- What is Grace Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Grace Therapeutics?
- What is Grace Therapeutics TTM operating profit year-on-year change?
What is Grace Therapeutics annual operating income?
The current annual operating profit of GRCE is -$11.37 M
What is the all time high annual operating profit for Grace Therapeutics?
Grace Therapeutics all-time high annual operating income is -$1.54 M
What is Grace Therapeutics annual operating profit year-on-year change?
Over the past year, GRCE annual operating income has changed by +$6.88 M (+37.70%)
What is Grace Therapeutics quarterly operating income?
The current quarterly operating profit of GRCE is -$4.83 M
What is the all time high quarterly operating profit for Grace Therapeutics?
Grace Therapeutics all-time high quarterly operating income is -$188.60 K
What is Grace Therapeutics quarterly operating profit year-on-year change?
Over the past year, GRCE quarterly operating income has changed by -$1.79 M (-58.76%)
What is Grace Therapeutics TTM operating income?
The current TTM operating profit of GRCE is -$16.10 M
What is the all time high TTM operating profit for Grace Therapeutics?
Grace Therapeutics all-time high TTM operating income is -$188.60 K
What is Grace Therapeutics TTM operating profit year-on-year change?
Over the past year, GRCE TTM operating income has changed by -$3.83 M (-31.23%)